Rebecca Lee

Has grant

The University of Manchester

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Open

Defining mechanisms and immunotherapeutic targets of tumour-microenvironment interaction driving immune tolerance in liver metastases

Open Date: 2022-10-01

Close Date: 2027-09-30

Grant: Close

A proof of concept, window trial of the IMmunological effects of AveLumab and Aspirin in Triple-Negative Breast Cancer

Open Date: 2019-06-01

Close Date: 2022-05-30

Articles (22)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (17)

Andre Freitas

The University of Manchester

UNITED KINGDOM

View details

Paweł Sobczuk

Medical University of Warsaw

POLAND

View details

Andrada Ianus

Lecturer

King’s College London

UNITED KINGDOM

View details

Matthew Vander Heiden

Massachusetts Institute of Technology

UNITED STATES

View details

Alexander Stockdale

NIHR Academic Clinical Lecturer

University of Liverpool

UNITED KINGDOM

View details

Alexander Christopher Jonathan van Akkooi

Associate Professor

Melanoma Institute Australia

AUSTRALIA

View details

Neta Erez

ISRAEL

View details

Matthias Scheffler

University Hospital Bonn

GERMANY

View details

Eva Maria Garrido Martin

Profesor Ayudante Doctor Biología Celular

SPAIN

View details

Osvaldo Graña Castro

Full-time professor

Universidad CEU San Pablo Facultad de Farmacia

SPAIN

View details

Jose Fernandez Alen

Profesor Asociado

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

Victoria Grace Woof

The University of Manchester

UNITED KINGDOM

View details

Thomas Cox

Laboratory Head (Faculty) - Matrix & Metastasis

Garvan Institute of Medical Research

AUSTRALIA

View details

Tim Robinson

University of Bristol

UNITED KINGDOM

View details

Mark Baxter

Academic, SCREDS Clinical Lecturer (Teaching and Scholarship)

University of Dundee

UNITED KINGDOM

View details

Paul Lorigan

The University of Manchester

UNITED KINGDOM

View details

Christoffer Gebhardt

University Medical Center Hamburg-Eppendorf

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rebecca Lee

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (22)

Late-Onset Immune-Related Adverse Events in Patients with Advanced Melanoma: The LATENT Study

Why do patients with cancer die?

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in <i>BRAF</i> V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.

Reinventing ESMO after the COVID-19 pandemic: moving towards a sustainable academic society

A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research.

Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Mining nucleic acid “omics” to boost liquid biopsy in cancer

Thyroid dysfunction after immune checkpoint inhibitors in a single-centre UK pan-cancer cohort: A retrospective study

Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy

Assessing the communication gap between AI models and healthcare professionals: Explainability, utility and trust in AI-driven clinical decision-making

Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology—shared perspectives from international consortia

Diversity, equity, and inclusion in the melanoma research community.

Potential of circulating tumor DNA to refine immunotherapy.

Adjuvant therapy for stage II melanoma

Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism

Circulating tumour DNA monitoring and early treatment for relapse: views from patients with early-stage melanoma

An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves

Circulating Tumour DNA in Melanoma-Clinic Ready?

COVID-19 in patients with cancer

Patient engagement in melanoma research: from bench to bedside

Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort.

The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers

Collaborators (17)

Andre Freitas

Paweł Sobczuk

Andrada Ianus

Matthew Vander Heiden

Alexander Stockdale

Alexander Christopher Jonathan van Akkooi

Neta Erez

Matthias Scheffler

Eva Maria Garrido Martin

Osvaldo Graña Castro

Jose Fernandez Alen

Victoria Grace Woof

Thomas Cox

Tim Robinson

Mark Baxter

Paul Lorigan

Christoffer Gebhardt

Make your next move.